Business Context and Reporting Period
Company: Omega Healthcare Investors, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2004
Business Overview: A Real Estate Investment Trust (REIT) investing in healthcare facilities, primarily skilled nursing facilities (SNFs), through master leases and mortgage loans. As of March 31, 2004, the portfolio consisted of 209 facilities in 28 states operated by 40 third-party operators.
Key Financial Metrics
| Metric | Q1 2004 | Q1 2003 |
|---|---|---|
| Total Revenues | $21.5 million | $24.3 million |
| Net (Loss) Income | $(10.3) million | $6.0 million |
| Net (Loss) Income Available to Common | $(53.7) million | $0.96 million |
| Basic EPS (Common) | $(1.30) | $0.03 |
| Cash from Operating Activities | $6.2 million | $13.3 million |
| Total Assets | $787.3 million | $726.7 million (Dec 31, 2003) |
| Total Liabilities | $337.3 million | $290.4 million (Dec 31, 2003) |
| Cash and Cash Equivalents | $62.3 million | $3.1 million (Dec 31, 2003) |
| Debt Outstanding | $313.5 million | N/A |
Note: Debt includes $10.0 million revolving credit line, $300.0 million unsecured borrowings, and $3.5 million other long-term borrowings.
Material Changes vs. Prior Period
- Net Loss vs. Profit: The company reported a net loss of $10.3 million compared to a net income of $6.0 million in Q1 2003. This was driven primarily by a $38.7 million non-cash charge related to the repurchase and conversion of Series C preferred stock and $19.1 million in refinancing costs.
- Revenue Decline: Total revenues decreased by $2.8 million, largely due to the absence of a $2.2 million litigation settlement recorded in Q1 2003 and the sale of a Baltimore asset in 2003.
- Expense Increase: Total expenses rose by $13.0 million to $31.5 million. This increase was primarily due to $19.1 million in refinancing charges (including a $6.5 million loss on the sale of an interest rate cap and $6.3 million in deferred financing cost write-offs), partially offset by a $4.6 million impairment provision recorded in 2003 that did not recur in 2004.
- Capital Structure Shift: The company completed a significant refinancing, issuing $200 million in 7% senior unsecured notes and a new $125 million credit facility, replacing a previous $225 million secured facility. Additionally, the company repurchased 700,000 shares of Series C preferred stock and converted the remainder to common stock.
- Portfolio Transition: The company re-leased its last owned and operated facility in January 2004, eliminating nursing home operating expenses for owned assets.
Guidance, Outlook, and Risks
- Dividend Policy: The Board declared a common stock dividend of $0.18 per share (a 5.9% increase) and authorized the redemption of all Series A preferred stock. Preferred dividends for Series B and D were also declared.
- Medicare/Medicaid Reimbursement: Management highlights significant risk regarding the expiration of temporary Medicare payment increases (20% and 6.7% add-ons) and potential future reductions in reimbursement rates, which could impair operators' ability to meet lease obligations.
- Bankruptcy Risk: The filing details risks associated with operator bankruptcies, specifically the potential for lease rejection or modification under the Bankruptcy Reform Act, which could limit recovery of unpaid rents.
- Liquidity: Management believes liquidity is adequate for the next 12 months, citing $102.9 million in availability under the new credit facility and proceeds from asset sales.
- Subsequent Events: Post-quarter, the company acquired three new facilities from Haven Healthcare ($26.0 million) and two from Senior Management ($9.4 million), and sold a closed facility in Illinois for a loss.
Investor Verification Checklist
- Refinancing Impact: Verify the long-term sustainability of the new debt structure ($200M notes + $125M credit facility) versus the previous secured facility, particularly regarding interest rate exposure given the sale of the interest rate cap.
- Preferred Stock Conversion Charge: Confirm the non-recurring nature of the $38.7 million charge related to Series C preferred stock to accurately assess core operating performance.
- Operator Concentration: Review the concentration risk where 40.2% of real estate investments are operated by four public companies (Sun, Advocat, Mariner, Emeritus).
- Medicare Rate Exposure: Assess the sensitivity of the portfolio's cash flows to potential future cuts in Medicare reimbursement rates following the expiration of temporary increases.
- Closed Asset Disposition: Monitor the timeline and valuation realization for the four remaining closed facilities not yet under contract for sale.